Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH, Sio KM, Wu CH, Xia YY, Lee JJ, Hu CH, Liu CC, Lu CL, Cheng CL, Lin KH, Tomiyasu H, Wang YS, Lin CS.
J Vet Intern Med. 2023 Nov-Dec;37(6):2391-2401. doi: 10.1111/jvim.16898. Epub 2023 Oct 14.
PMID:37837297
Fibrinogen degradation products in plasma following induced hyperfibrinolysis.
Chek JB, Panchenko NI.
East Afr Med J. 2000 Apr;77(4):217-20.
PMID:12858907
Measuring plasma fibrinogen levels in patients with liver cirrhosis. The occurrence of proteolytic fibrin(ogen) degradation products and their influence on several fibrinogen assays.
de Maat MP, Nieuwenhuizen W, Knot EA, van Buuren HR, Swart GR.
Thromb Res. 1995 May 15;78(4):353-62. doi: 10.1016/0049-3848(95)91463-u.
PMID:7631315
Influence of fibrinogen degradation products on thrombin time, activated partial thromboplastin time and prothrombin time of canine plasma.